763 related articles for article (PubMed ID: 28646391)
1. The Changing Landscape of Alopecia Areata: An Introduction.
Han G
Adv Ther; 2017 Jul; 34(7):1584-1585. PubMed ID: 28646391
[TBL] [Abstract][Full Text] [Related]
2. The Changing Landscape of Alopecia Areata: The Translational Landscape.
Wang ECE; Christiano AM
Adv Ther; 2017 Jul; 34(7):1586-1593. PubMed ID: 28646392
[TBL] [Abstract][Full Text] [Related]
3. The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm.
Renert-Yuval Y; Guttman-Yassky E
Adv Ther; 2017 Jul; 34(7):1594-1609. PubMed ID: 28646393
[TBL] [Abstract][Full Text] [Related]
4. Systemic treatment for alopecia areata.
Otberg N
Dermatol Ther; 2011; 24(3):320-5. PubMed ID: 21689241
[TBL] [Abstract][Full Text] [Related]
5. Alopecia Areata: Current Treatments and New Directions.
Dahabreh D; Jung S; Renert-Yuval Y; Bar J; Del Duca E; Guttman-Yassky E
Am J Clin Dermatol; 2023 Nov; 24(6):895-912. PubMed ID: 37606849
[TBL] [Abstract][Full Text] [Related]
6. Alopecia areata: A multifactorial autoimmune condition.
Simakou T; Butcher JP; Reid S; Henriquez FL
J Autoimmun; 2019 Mar; 98():74-85. PubMed ID: 30558963
[TBL] [Abstract][Full Text] [Related]
7. [JAK INHIBITORS FOR THE TREATMENT OF ALOPECIA AREATA].
Ramot Y; Zlotogorski A
Harefuah; 2020 Jan; 159(1):38-42. PubMed ID: 31930807
[TBL] [Abstract][Full Text] [Related]
8. Could azathioprine be considered as a therapeutic alternative in the treatment of alopecia areata? A pilot study.
Farshi S; Mansouri P; Safar F; Khiabanloo SR
Int J Dermatol; 2010 Oct; 49(10):1188-93. PubMed ID: 20883409
[TBL] [Abstract][Full Text] [Related]
9. Overview of alopecia areata.
Hordinsky MK
J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S13-5. PubMed ID: 24326541
[TBL] [Abstract][Full Text] [Related]
10. Emerging drugs for alopecia areata: JAK inhibitors.
Iorizzo M; Tosti A
Expert Opin Emerg Drugs; 2018 Mar; 23(1):77-81. PubMed ID: 29466675
[TBL] [Abstract][Full Text] [Related]
11. Understanding autoimmunity of vitiligo and alopecia areata.
Rork JF; Rashighi M; Harris JE
Curr Opin Pediatr; 2016 Aug; 28(4):463-9. PubMed ID: 27191524
[TBL] [Abstract][Full Text] [Related]
12. Alopecia areata.
Perera E; Yip L; Sinclair R
Curr Probl Dermatol; 2015; 47():67-75. PubMed ID: 26370645
[TBL] [Abstract][Full Text] [Related]
13. Alopecia areata: evidence-based treatments.
Garg S; Messenger AG
Semin Cutan Med Surg; 2009 Mar; 28(1):15-8. PubMed ID: 19341938
[TBL] [Abstract][Full Text] [Related]
14. Oral administration of cyclosporin A in patients with severe alopecia areata.
Rallis E; Nasiopoulou A; Kouskoukis C; Roussaki-Schulze A; Koumantaki E; Karpouzis A; Arvanitis A
Int J Tissue React; 2005; 27(3):107-10. PubMed ID: 16372476
[TBL] [Abstract][Full Text] [Related]
15. From Targets to Treatments: Bridging Autoimmune Research to Advance Understanding of Alopecia Areata.
Kranz D; Ellison A; Frelinger JA; Mackay-Wiggan J; Norris DA
J Investig Dermatol Symp Proc; 2015 Nov; 17(2):1-5. PubMed ID: 26551934
[TBL] [Abstract][Full Text] [Related]
16. Alopecia areata: a tissue specific autoimmune disease of the hair follicle.
Gilhar A; Kalish RS
Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of methotrexate in alopecia areata.
Hammerschmidt M; Mulinari Brenner F
An Bras Dermatol; 2014; 89(5):729-34. PubMed ID: 25184911
[TBL] [Abstract][Full Text] [Related]
18. Alopecia areata: a review of disease pathogenesis.
Rajabi F; Drake LA; Senna MM; Rezaei N
Br J Dermatol; 2018 Nov; 179(5):1033-1048. PubMed ID: 29791718
[TBL] [Abstract][Full Text] [Related]
19. Baricitinib as the first systemic treatment for severe alopecia areata.
Kincaid CM; Arnold JD; Mesinkovska NA
Expert Rev Clin Immunol; 2023 Jun; 19(6):565-573. PubMed ID: 37042112
[TBL] [Abstract][Full Text] [Related]
20. SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction.
Gao Z; Jin YQ; Wu W
Oncotarget; 2017 May; 8(20):33432-33443. PubMed ID: 28418931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
